US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

49.09

-1.4300-2.83%

Post-market: 49.200.1100+0.22%19:59 EDT

Volume:592.57K

Turnover:29.71M

Market Cap:3.50B

PE:-15.77

High:51.11

Open:50.70

Low:49.01

Close:50.52

52wk High:94.90

52wk Low:18.26

Shares:71.31M

Float Shares:54.64M

Volume Ratio:0.80

T/O Rate:1.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1128

EPS(LYR):-2.3852

ROE:-20.21%

ROA:-14.95%

PB:2.58

PE(LYR):-20.58

Loading ...

Overview Company News Filings

This biotech is working on a GLP-1 pill that could be better than the Wegovy version

Eli Lilly Shares Decline Over 4% as Structure Therapeutics Reports Positive Data for Experimental Weight-Loss Drug

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

BUZZ-U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, Nvidia

Structure Therapeutics Inc. : H.c. Wainwright Cuts Target Price to $100 From $114

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, Micron, Customers Bancorp

Structure’s GLP-1 pill could put company on M&A radar, Barron’s says

Weight Loss Pill from Structure Therapeutics Trimmed the Most Pounds Yet. Is the Biotech a Takeover Candidate? -- Barrons.com

Structure Therapeutics Shares up 6% After Disclosing Mid-Stage Trial Results of Experimental Obesity Pill

THOMSON REUTERS

Structure Stock Rises on Positive Data From Oral GLP-1 Study

This biotech is working on an GLP-1 drug that could be better than the Wegovy pill

BRIEF-Structure Therapeutics Reports Positive Topline Data From Phase 2 Access Ii Trial With Once-Daily Oral Small Molecule Glp-1 Receptor Agonist, Aleniglipron

Structure Therapeutics Shares Reverse Course; Last up 13.5% Premarket After Disclosing Mid-Stage Trial Results of Experimental Obesity Pill

THOMSON REUTERS

Structure Therapeutics Shares Down 1.6% Premarket After Disclosing Mid-Stage Trial Results of Experimental Obesity Pill

THOMSON REUTERS

Structure's obesity pill shows up to 16.3% weight loss in study

Structure Therapeutics reports 16.3% placebo-adjusted weight loss at 44 weeks in Phase 2 ACCESS II trial of oral GLP-1 agonist aleniglipron

Structure Therapeutics Inc - Interim Data Shows 2.0%-3.4% Ae-Related Discontinuations With 2.5 Mg Starting Dose

THOMSON REUTERS

Structure Therapeutics Inc - Access Ole Study Shows Continued Weight Loss up to 16.2% With 120 Mg at 56 Weeks

THOMSON REUTERS

Structure Therapeutics Inc - End-of-Phase 2 FDA Meeting Scheduled for Q2 2026; Phase 3 Initiation on Track for 2H 2026

THOMSON REUTERS

Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GPCR/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GPCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":49.09,"timestamp":1787342400000,"preClose":50.52,"halted":0,"volume":592574,"hourTrading":{"tag":"盘后","latestPrice":49.2,"preClose":49.09,"latestTime":"19:59 EDT","volume":44750,"amount":2196926.26,"timestamp":1787356775142,"change":0.11,"changeRate":0.002241,"amplitude":0.010389},"delay":0,"changeRate":-0.028305621536025328,"floatShares":54641899,"shares":71309857,"eps":-3.1128,"marketStatus":"Market Closed","change":-1.43,"latestTime":"08-21 16:00:00 EDT","open":50.7,"high":51.11,"low":49.01,"amount":29714636.859202,"amplitude":0.041568,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.1128,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":50.52,"preHourTrading":{"tag":"盘前","latestPrice":51.2,"preClose":50.52,"latestTime":"09:15 EDT","volume":721,"amount":36627.699087,"timestamp":1787318123448,"change":0.68,"changeRate":0.01346,"amplitude":0.054236},"postHourTrading":{"tag":"盘后","latestPrice":49.2,"preClose":49.09,"latestTime":"19:59 EDT","volume":44750,"amount":2196926.26,"timestamp":1787356775142,"change":0.11,"changeRate":0.002241,"amplitude":0.010389},"volumeRatio":0.8033914747715426,"impliedVol":0.7978,"impliedVolPercentile":0.5777},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","floatShares":54641899,"roa":"-14.95%","roe":"-20.21%","lyrEps":-2.385222,"volumeRatio":0.8033914747715426,"shares":71309857,"dividePrice":0,"high":51.11,"amplitude":0.041568,"preClose":50.52,"low":49.01,"week52Low":18.264,"pbRate":"2.58","week52High":94.9,"institutionHeld":0,"latestPrice":49.09,"eps":-3.1128,"divideRate":0,"volume":592574,"delay":0,"ttmEps":-3.1128,"open":50.7,"prevYearClose":69.55,"prevWeekClose":54.51,"prevMonthClose":48.04,"prevQuarterClose":53.67,"fiveDayClose":54.51,"twentyDayClose":49.12,"sixtyDayClose":39.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GPCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"GPCR","fiscalQuarterEnding":"2026/06","expectedEps":-0.39,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2026-05-07","symbol":"GPCR","fiscalQuarterEnding":"2026/03","expectedEps":-0.39,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2026-02-26","symbol":"GPCR","fiscalQuarterEnding":"2025/12","expectedEps":-0.35,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-06","symbol":"GPCR","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-08-06","symbol":"GPCR","fiscalQuarterEnding":"2025/06","expectedEps":-0.28,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GPCR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GPCR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3529,"buy":0.5882,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5882,"analysts":17,"updateTime":1777348800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GPCR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GPCR","date":"2026-08-21","current":-15.770368,"percent":0.668591,"low":-50.180001,"twenty":-24.436431,"median":-19.854838,"eighty":-10.567565,"high":-5.211405,"avg":-19.432697,"sd":8.246779,"marketCap":3602573975},"quantilePoints":[{"date":"2023-02-03","current":-25.001825,"twenty":-43.272389,"median":-43.272389,"eighty":-32.310051,"marketCap":951294422},{"date":"2023-02-10","current":-22.116999,"twenty":-35.964163,"median":-23.496907,"eighty":-22.21316,"marketCap":841529681},{"date":"2023-02-17","current":-21.285207,"twenty":-24.521021,"median":-22.645883,"eighty":-21.915061,"marketCap":809880847},{"date":"2023-02-24","current":-23.36709,"twenty":-23.715192,"median":-22.645883,"eighty":-21.847749,"marketCap":889094402},{"date":"2023-03-03","current":-25.530709,"twenty":-24.422936,"median":-22.718004,"eighty":-21.972757,"marketCap":971417957},{"date":"2023-03-10","current":-22.636267,"twenty":-24.85566,"median":-22.790125,"eighty":-22.063149,"marketCap":861287334},{"date":"2023-03-17","current":-22.232392,"twenty":-24.422936,"median":-22.70358,"eighty":-22.09392,"marketCap":845920270},{"date":"2023-03-24","current":-21.876596,"twenty":-23.762311,"median":-22.568955,"eighty":-21.891982,"marketCap":832382619},{"date":"2023-03-31","current":-16.960589,"twenty":-23.565181,"median":-22.314128,"eighty":-21.634271,"marketCap":870434396},{"date":"2023-04-06","current":-17.823234,"twenty":-23.376706,"median":-22.232392,"eighty":-21.285207,"marketCap":914706175},{"date":"2023-04-14","current":-17.473898,"twenty":-23.36709,"median":-22.116999,"eighty":-18.643102,"marketCap":896777933},{"date":"2023-04-21","current":-17.210114,"twenty":-23.194,"median":-22.059302,"eighty":-17.623613,"marketCap":883240282},{"date":"2023-04-28","current":-17.815518,"twenty":-23.078607,"median":-21.876596,"eighty":-17.586227,"marketCap":914310203},{"date":"2023-05-05","current":-17.709107,"twenty":-22.982446,"median":-21.689083,"eighty":-17.623613,"marketCap":908849077},{"date":"2023-05-12","current":-17.00755,"twenty":-22.790125,"median":-21.491953,"eighty":-17.586227,"marketCap":956079400},{"date":"2023-05-19","current":-15.32957,"twenty":-22.780509,"median":-20.818827,"eighty":-17.473898,"marketCap":861751761},{"date":"2023-05-26","current":-19.808636,"twenty":-22.761276,"median":-19.808636,"eighty":-17.466769,"marketCap":1113542462},{"date":"2023-06-02","current":-21.830342,"twenty":-22.668962,"median":-20.674586,"eighty":-17.472472,"marketCap":1227192672},{"date":"2023-06-09","current":-23.110075,"twenty":-22.668962,"median":-21.38858,"eighty":-17.563702,"marketCap":1299132872},{"date":"2023-06-16","current":-21.061141,"twenty":-22.668962,"median":-21.491953,"eighty":-17.586212,"marketCap":1183952020},{"date":"2023-06-23","current":-21.782692,"twenty":-22.640113,"median":-21.568882,"eighty":-17.608538,"marketCap":1224514048},{"date":"2023-06-30","current":-27.561913,"twenty":-22.772816,"median":-21.571672,"eighty":-17.623492,"marketCap":1549392931},{"date":"2023-07-07","current":-24.451072,"twenty":-23.059375,"median":-21.612515,"eighty":-17.625039,"marketCap":1374517018},{"date":"2023-07-14","current":-21.428724,"twenty":-23.103781,"median":-21.707815,"eighty":-17.644282,"marketCap":1204615694},{"date":"2023-07-21","current":-23.069233,"twenty":-23.103781,"median":-21.780436,"eighty":-17.700571,"marketCap":1296836908},{"date":"2023-07-28","current":-23.552536,"twenty":-23.333385,"median":-21.782692,"eighty":-17.727736,"marketCap":1324005814},{"date":"2023-08-04","current":-21.592094,"twenty":-23.51737,"median":-21.782692,"eighty":-17.804907,"marketCap":1213799550},{"date":"2023-08-11","current":-19.978813,"twenty":-23.374783,"median":-21.781564,"eighty":-17.817061,"marketCap":1123108978},{"date":"2023-08-18","current":-16.072919,"twenty":-23.333385,"median":-21.735043,"eighty":-17.644282,"marketCap":1053531639},{"date":"2023-08-25","current":-16.66259,"twenty":-23.197654,"median":-21.646551,"eighty":-17.586168,"marketCap":1092182818},{"date":"2023-09-01","current":-16.458249,"twenty":-23.185384,"median":-21.592094,"eighty":-17.468195,"marketCap":1078788845},{"date":"2023-09-08","current":-16.680105,"twenty":-23.150918,"median":-21.568882,"eighty":-17.319402,"marketCap":1093330873},{"date":"2023-09-15","current":-18.326514,"twenty":-23.110075,"median":-21.460338,"eighty":-17.211393,"marketCap":1201248026},{"date":"2023-09-22","current":-19.937893,"twenty":-23.078607,"median":-21.067948,"eighty":-17.309925,"marketCap":1306869070},{"date":"2023-09-29","current":-21.876218,"twenty":-23.069233,"median":-21.012104,"eighty":-17.319402,"marketCap":1433920470},{"date":"2023-10-06","current":-37.165618,"twenty":-23.194,"median":-21.285207,"eighty":-17.395476,"marketCap":2436094784},{"date":"2023-10-13","current":-44.162453,"twenty":-23.552536,"median":-21.525005,"eighty":-17.459473,"marketCap":2894716299},{"date":"2023-10-20","current":-45.222784,"twenty":-23.852048,"median":-21.571672,"eighty":-17.466769,"marketCap":2964217822},{"date":"2023-10-27","current":-47.275909,"twenty":-23.892891,"median":-21.592094,"eighty":-17.469621,"marketCap":3098794020},{"date":"2023-11-03","current":-48.538851,"twenty":-24.328544,"median":-21.646551,"eighty":-17.490333,"marketCap":3181576088},{"date":"2023-11-10","current":-38.273225,"twenty":-24.864943,"median":-21.735043,"eighty":-17.514986,"marketCap":2508695101},{"date":"2023-11-17","current":-27.570058,"twenty":-25.04304,"median":-21.781564,"eighty":-17.543453,"marketCap":2122673903},{"date":"2023-11-24","current":-32.691508,"twenty":-27.365869,"median":-21.782692,"eighty":-17.586168,"marketCap":2516984612},{"date":"2023-12-01","current":-35.337541,"twenty":-28.3175,"median":-21.830342,"eighty":-17.593664,"marketCap":2720707940},{"date":"2023-12-08","current":-37.983573,"twenty":-33.138225,"median":-21.904522,"eighty":-17.623452,"marketCap":2924431267},{"date":"2023-12-15","current":-37.177707,"twenty":-34.105722,"median":-22.049686,"eighty":-17.625039,"marketCap":2862386033},{"date":"2023-12-22","current":-20.939825,"twenty":-34.105722,"median":-22.001606,"eighty":-17.644282,"marketCap":1612198995},{"date":"2023-12-29","current":-23.446258,"twenty":-34.065552,"median":-22.068918,"eighty":-17.684898,"marketCap":1805174329},{"date":"2024-01-05","current":-26.187472,"twenty":-34.000259,"median":-22.102574,"eighty":-17.702705,"marketCap":2016225834},{"date":"2024-01-12","current":-28.789086,"twenty":-33.67371,"median":-22.232392,"eighty":-17.746366,"marketCap":2216529345},{"date":"2024-01-19","current":-27.710368,"twenty":-33.290514,"median":-22.259189,"eighty":-17.804907,"marketCap":2133476670},{"date":"2024-01-26","current":-26.745867,"twenty":-33.138225,"median":-22.283013,"eighty":-17.817061,"marketCap":2059217807},{"date":"2024-02-02","current":-28.598724,"twenty":-32.691508,"median":-22.44298,"eighty":-17.823234,"marketCap":2201872991},{"date":"2024-02-09","current":-29.823387,"twenty":-32.667396,"median":-22.576119,"eighty":-17.835432,"marketCap":2296162205},{"date":"2024-02-16","current":-28.427399,"twenty":-32.293017,"median":-22.636267,"eighty":-17.890184,"marketCap":2188682272},{"date":"2024-02-23","current":-26.035182,"twenty":-31.181303,"median":-22.647193,"eighty":-17.91403,"marketCap":2004500750},{"date":"2024-03-01","current":-25.743294,"twenty":-31.092467,"median":-22.775115,"eighty":-17.959972,"marketCap":1982027673},{"date":"2024-03-08","current":-22.849791,"twenty":-30.933832,"median":-22.849791,"eighty":-18.031985,"marketCap":1759251085},{"date":"2024-03-15","current":-18.291889,"twenty":-29.823387,"median":-22.775115,"eighty":-18.031985,"marketCap":1639319082},{"date":"2024-03-22","current":-22.815466,"twenty":-29.601298,"median":-22.761276,"eighty":-18.070517,"marketCap":2044722039},{"date":"2024-03-28","current":-22.311113,"twenty":-29.398245,"median":-22.645883,"eighty":-18.070517,"marketCap":1999521939},{"date":"2024-04-05","current":-20.434088,"twenty":-29.301795,"median":-22.601624,"eighty":-18.089549,"marketCap":1831303011},{"date":"2024-04-12","current":-20.928042,"twenty":-29.107626,"median":-22.568955,"eighty":-18.098906,"marketCap":1875571150},{"date":"2024-04-19","current":-18.81184,"twenty":-29.061939,"median":-22.455039,"eighty":-18.224405,"marketCap":1685917123},{"date":"2024-04-26","current":-20.267704,"twenty":-28.863962,"median":-22.311113,"eighty":-18.256547,"marketCap":1816391638},{"date":"2024-05-03","current":-20.281918,"twenty":-28.794162,"median":-22.289169,"eighty":-18.270537,"marketCap":1817665530},{"date":"2024-05-10","current":-20.105056,"twenty":-28.789086,"median":-22.270856,"eighty":-18.288305,"marketCap":1801815151},{"date":"2024-05-17","current":-17.123915,"twenty":-28.636796,"median":-22.232392,"eighty":-18.098906,"marketCap":1672681180},{"date":"2024-05-24","current":-18.288418,"twenty":-28.476893,"median":-22.116999,"eighty":-18.062811,"marketCap":1786430959},{"date":"2024-05-31","current":-16.11295,"twenty":-28.435013,"median":-22.068918,"eighty":-17.902107,"marketCap":1573929112},{"date":"2024-06-07","current":-26.55105,"twenty":-28.381712,"median":-22.102574,"eighty":-17.902107,"marketCap":2593533072},{"date":"2024-06-14","current":-24.646705,"twenty":-28.337752,"median":-22.198735,"eighty":-17.932407,"marketCap":2407514791},{"date":"2024-06-21","current":-22.312809,"twenty":-28.3175,"median":-22.24579,"eighty":-17.974375,"marketCap":2179537500},{"date":"2024-06-28","current":-18.680713,"twenty":-28.3175,"median":-22.24579,"eighty":-18.00318,"marketCap":1824750754},{"date":"2024-07-05","current":-17.874111,"twenty":-28.267548,"median":-22.198735,"eighty":-17.932407,"marketCap":1745961056},{"date":"2024-07-12","current":-20.408464,"twenty":-28.068249,"median":-22.08815,"eighty":-17.932407,"marketCap":1993519219},{"date":"2024-07-15","current":-20.943017,"twenty":-28.006064,"median":-22.078534,"eighty":-17.941595,"marketCap":2045734877},{"date":"2024-08-02","current":-17.387286,"twenty":-27.943879,"median":-22.068918,"eighty":-17.908069,"marketCap":1698407510},{"date":"2024-08-09","current":-16.461364,"twenty":-27.802578,"median":-21.942986,"eighty":-17.823234,"marketCap":1607962532},{"date":"2024-08-16","current":-20.792004,"twenty":-27.780694,"median":-21.876596,"eighty":-17.821691,"marketCap":2088244945},{"date":"2024-08-23","current":-22.295452,"twenty":-27.74971,"median":-21.929398,"eighty":-17.823234,"marketCap":2239243758},{"date":"2024-08-30","current":-21.822777,"twenty":-27.716713,"median":-21.953525,"eighty":-17.863936,"marketCap":2191770646},{"date":"2024-09-06","current":-21.851252,"twenty":-27.691332,"median":-21.926349,"eighty":-17.874111,"marketCap":2194630472},{"date":"2024-09-13","current":-22.944669,"twenty":-27.671026,"median":-21.901472,"eighty":-17.880178,"marketCap":2304447790},{"date":"2024-09-20","current":-22.067657,"twenty":-27.608415,"median":-21.926349,"eighty":-17.902107,"marketCap":2216365150},{"date":"2024-09-27","current":-23.650834,"twenty":-27.565171,"median":-22.001606,"eighty":-17.941595,"marketCap":2375371475},{"date":"2024-10-04","current":-24.083644,"twenty":-27.536769,"median":-22.068918,"eighty":-18.000093,"marketCap":2418840830},{"date":"2024-10-11","current":-22.130301,"twenty":-27.481934,"median":-22.12365,"eighty":-18.029927,"marketCap":2222656767},{"date":"2024-10-18","current":-22.563112,"twenty":-27.163394,"median":-22.116999,"eighty":-18.055104,"marketCap":2266126122},{"date":"2024-10-25","current":-21.333018,"twenty":-26.967956,"median":-22.11226,"eighty":-18.070517,"marketCap":2142581639},{"date":"2024-10-31","current":-21.560813,"twenty":-26.932422,"median":-22.097835,"eighty":-18.080033,"marketCap":2165460247},{"date":"2024-11-08","current":-21.839862,"twenty":-26.875803,"median":-22.107521,"eighty":-18.096607,"marketCap":2193486542},{"date":"2024-11-15","current":-19.500107,"twenty":-26.820843,"median":-22.068288,"eighty":-18.16223,"marketCap":2155736838},{"date":"2024-11-22","current":-15.573182,"twenty":-26.740791,"median":-22.039183,"eighty":-18.047398,"marketCap":1721615252},{"date":"2024-11-29","current":-17.170432,"twenty":-26.702879,"median":-21.932448,"eighty":-17.923218,"marketCap":1898191276},{"date":"2024-12-06","current":-16.181125,"twenty":-26.575564,"median":-21.883856,"eighty":-17.833409,"marketCap":1788823393},{"date":"2024-12-13","current":-16.424567,"twenty":-26.524021,"median":-21.851252,"eighty":-17.817061,"marketCap":1815735909},{"date":"2024-12-20","current":-15.523314,"twenty":-26.386717,"median":-21.835102,"eighty":-17.715324,"marketCap":1716102339},{"date":"2024-12-27","current":-15.30059,"twenty":-26.269962,"median":-21.822777,"eighty":-17.687076,"marketCap":1691480250},{"date":"2025-01-03","current":-14.601342,"twenty":-26.20397,"median":-21.78933,"eighty":-17.625803,"marketCap":1614178343},{"date":"2025-01-10","current":-14.005686,"twenty":-26.17605,"median":-21.782692,"eighty":-17.604018,"marketCap":1548328570},{"date":"2025-01-17","current":-13.974608,"twenty":-26.160821,"median":-21.780436,"eighty":-17.514986,"marketCap":1544892930},{"date":"2025-01-24","current":-14.482211,"twenty":-26.10752,"median":-21.737354,"eighty":-17.469621,"marketCap":1601008389},{"date":"2025-01-31","current":-15.7046,"twenty":-26.035182,"median":-21.700984,"eighty":-17.381485,"marketCap":1736143575},{"date":"2025-02-07","current":-15.549212,"twenty":-26.032644,"median":-21.680405,"eighty":-17.295679,"marketCap":1718965373},{"date":"2025-02-14","current":-12.622728,"twenty":-25.9819,"median":-21.605123,"eighty":-17.234446,"marketCap":1395442576},{"date":"2025-02-21","current":-12.115125,"twenty":-25.903236,"median":-21.581883,"eighty":-17.21037,"marketCap":1339327118},{"date":"2025-02-28","current":-11.819887,"twenty":-25.84482,"median":-21.567582,"eighty":-17.171628,"marketCap":1306688535},{"date":"2025-03-07","current":-11.01217,"twenty":-25.735679,"median":-21.559435,"eighty":-17.124089,"marketCap":1349277189},{"date":"2025-03-14","current":-9.547313,"twenty":-25.689992,"median":-21.491953,"eighty":-17.045645,"marketCap":1169794078},{"date":"2025-03-21","current":-10.235281,"twenty":-25.609403,"median":-21.417887,"eighty":-16.960589,"marketCap":1254088063},{"date":"2025-03-28","current":-9.33203,"twenty":-25.527539,"median":-21.321628,"eighty":-16.93886,"marketCap":1143416369},{"date":"2025-04-04","current":-7.64253,"twenty":-25.480594,"median":-21.202701,"eighty":-16.831205,"marketCap":936408691},{"date":"2025-04-11","current":-7.043483,"twenty":-25.340669,"median":-21.061141,"eighty":-16.666093,"marketCap":863009847},{"date":"2025-04-17","current":-8.672143,"twenty":-25.329214,"median":-21.042579,"eighty":-16.563339,"marketCap":1062562954},{"date":"2025-04-25","current":-11.068331,"twenty":-25.25285,"median":-20.951128,"eighty":-16.426861,"marketCap":1356158331},{"date":"2025-05-02","current":-12.790591,"twenty":-25.171712,"median":-20.933479,"eighty":-16.305436,"marketCap":1567180008},{"date":"2025-05-09","current":-12.551909,"twenty":-25.070517,"median":-20.891345,"eighty":-16.181125,"marketCap":1537935156},{"date":"2025-05-16","current":-9.774326,"twenty":-25.068859,"median":-20.829252,"eighty":-16.056814,"marketCap":1400885752},{"date":"2025-05-23","current":-9.895696,"twenty":-25.0453,"median":-20.693431,"eighty":-15.839386,"marketCap":1418280862},{"date":"2025-05-30","current":-9.000467,"twenty":-25.01052,"median":-20.672234,"eighty":-15.745511,"marketCap":1289973912},{"date":"2025-06-06","current":-8.619091,"twenty":-25.001825,"median":-20.550917,"eighty":-15.544032,"marketCap":1235314001},{"date":"2025-06-13","current":-8.920177,"twenty":-24.996225,"median":-20.487391,"eighty":-15.387426,"marketCap":1278466562},{"date":"2025-06-20","current":-8.679308,"twenty":-24.952868,"median":-20.449033,"eighty":-14.973238,"marketCap":1243944513},{"date":"2025-06-27","current":-8.462526,"twenty":-24.918331,"median":-20.434088,"eighty":-14.66039,"marketCap":1212874668},{"date":"2025-07-03","current":-8.175491,"twenty":-24.875783,"median":-20.408464,"eighty":-14.607558,"marketCap":1171735893},{"date":"2025-07-11","current":-7.587369,"twenty":-24.818526,"median":-20.385744,"eighty":-14.451133,"marketCap":1087444556},{"date":"2025-07-18","current":-7.840282,"twenty":-24.807686,"median":-20.281918,"eighty":-14.123781,"marketCap":1123692707},{"date":"2025-07-25","current":-7.334457,"twenty":-24.781668,"median":-20.180483,"eighty":-13.987039,"marketCap":1051196404},{"date":"2025-08-01","current":-7.145777,"twenty":-24.722332,"median":-20.085721,"eighty":-13.108576,"marketCap":1024154132},{"date":"2025-08-08","current":-5.211405,"twenty":-24.651853,"median":-19.971704,"eighty":-12.812535,"marketCap":932580977},{"date":"2025-08-15","current":-5.964179,"twenty":-24.61951,"median":-19.937893,"eighty":-12.626872,"marketCap":1067289809},{"date":"2025-08-22","current":-6.234546,"twenty":-24.540145,"median":-19.829477,"eighty":-12.490132,"marketCap":1115672078},{"date":"2025-08-29","current":-6.160517,"twenty":-24.4698,"median":-19.66456,"eighty":-12.119485,"marketCap":1102424552},{"date":"2025-09-05","current":-6.360074,"twenty":-24.389808,"median":-19.576169,"eighty":-11.77845,"marketCap":1138135274},{"date":"2025-09-12","current":-6.720564,"twenty":-24.139365,"median":-19.456275,"eighty":-11.057099,"marketCap":1202644966},{"date":"2025-09-19","current":-7.47695,"twenty":-24.11098,"median":-19.134734,"eighty":-10.896967,"marketCap":1338000122},{"date":"2025-09-26","current":-8.043434,"twenty":-24.072254,"median":-19.014985,"eighty":-10.567565,"marketCap":1439372495},{"date":"2025-10-03","current":-8.568076,"twenty":-24.020356,"median":-18.941828,"eighty":-10.325716,"marketCap":1533257136},{"date":"2025-10-10","current":-9.833009,"twenty":-23.986828,"median":-18.81071,"eighty":-10.186609,"marketCap":1759617036},{"date":"2025-10-17","current":-8.87063,"twenty":-23.947347,"median":-18.74276,"eighty":-9.917033,"marketCap":1587399198},{"date":"2025-10-24","current":-8.548764,"twenty":-23.914099,"median":-18.661907,"eighty":-9.852324,"marketCap":1529801259},{"date":"2025-10-31","current":-10.370526,"twenty":-23.886602,"median":-18.351918,"eighty":-9.836476,"marketCap":1855805594},{"date":"2025-11-07","current":-10.772858,"twenty":-23.868757,"median":-18.327399,"eighty":-9.850579,"marketCap":1927803018},{"date":"2025-11-14","current":-10.08006,"twenty":-23.852048,"median":-18.288418,"eighty":-9.817863,"marketCap":2123717400},{"date":"2025-11-21","current":-9.889979,"twenty":-23.841601,"median":-18.256152,"eighty":-9.836476,"marketCap":2083670157},{"date":"2025-11-28","current":-10.313341,"twenty":-23.799814,"median":-18.097181,"eighty":-9.841018,"marketCap":2172866288},{"date":"2025-12-05","current":-9.460856,"twenty":-23.776121,"median":-18.070517,"eighty":-9.814076,"marketCap":1993260474},{"date":"2025-12-12","current":-19.422835,"twenty":-23.650834,"median":-18.082412,"eighty":-9.833009,"marketCap":4092100041},{"date":"2025-12-19","current":-17.985707,"twenty":-23.62393,"median":-18.070517,"eighty":-9.841018,"marketCap":3789318618},{"date":"2025-12-26","current":-22.869735,"twenty":-23.621272,"median":-18.100056,"eighty":-9.848479,"marketCap":4818310220},{"date":"2026-01-02","current":-22.823793,"twenty":-23.615623,"median":-18.255492,"eighty":-9.851048,"marketCap":4808630734},{"date":"2026-01-09","current":-21.980412,"twenty":-23.576442,"median":-18.281194,"eighty":-9.851517,"marketCap":4630943013},{"date":"2026-01-16","current":-27.900487,"twenty":-23.621936,"median":-18.326514,"eighty":-9.853937,"marketCap":5878214018},{"date":"2026-01-23","current":-30.148409,"twenty":-23.790337,"median":-18.349084,"eighty":-9.86147,"marketCap":6351817477},{"date":"2026-01-30","current":-28.599475,"twenty":-23.883185,"median":-18.63625,"eighty":-9.874048,"marketCap":6025480495},{"date":"2026-02-06","current":-24.024872,"twenty":-24.012922,"median":-18.680713,"eighty":-9.881446,"marketCap":5061680173},{"date":"2026-02-13","current":-23.64092,"twenty":-24.104146,"median":-18.735704,"eighty":-9.886523,"marketCap":4980787319},{"date":"2026-02-20","current":-22.141212,"twenty":-24.072254,"median":-18.787312,"eighty":-9.891122,"marketCap":4664821216},{"date":"2026-02-27","current":-21.248606,"twenty":-24.026331,"median":-18.905431,"eighty":-9.903769,"marketCap":4476762617},{"date":"2026-03-06","current":-29.951815,"twenty":-24.389808,"median":-18.958825,"eighty":-9.939515,"marketCap":4229256176},{"date":"2026-03-13","current":-27.383083,"twenty":-24.63457,"median":-19.091174,"eighty":-9.953915,"marketCap":3866546098},{"date":"2026-03-20","current":-25.316057,"twenty":-24.813106,"median":-19.247915,"eighty":-9.965451,"marketCap":3574677833},{"date":"2026-03-27","current":-23.178791,"twenty":-24.786548,"median":-19.412443,"eighty":-10.00684,"marketCap":3272891714},{"date":"2026-04-02","current":-25.170562,"twenty":-24.791427,"median":-19.500107,"eighty":-10.024679,"marketCap":3554133708},{"date":"2026-04-10","current":-27.664038,"twenty":-24.924896,"median":-19.588971,"eighty":-10.070397,"marketCap":3906217513},{"date":"2026-04-17","current":-26.841241,"twenty":-25.001825,"median":-19.762743,"eighty":-10.08006,"marketCap":3790036942},{"date":"2026-04-24","current":-23.59019,"twenty":-25.001825,"median":-19.852578,"eighty":-10.16646,"marketCap":3330982000},{"date":"2026-05-01","current":-20.863024,"twenty":-25.001825,"median":-19.937893,"eighty":-10.183801,"marketCap":2945900742},{"date":"2026-05-08","current":-19.705365,"twenty":-24.994825,"median":-19.961493,"eighty":-10.197841,"marketCap":2782437010},{"date":"2026-05-15","current":-16.62279,"twenty":-24.933886,"median":-19.910742,"eighty":-10.230435,"marketCap":2831476129},{"date":"2026-05-22","current":-16.184689,"twenty":-24.924896,"median":-19.829477,"eighty":-10.235281,"marketCap":2756851382},{"date":"2026-05-29","current":-20.218762,"twenty":-24.916142,"median":-19.78569,"eighty":-10.28472,"marketCap":2854929621},{"date":"2026-06-05","current":-19.660066,"twenty":-24.837612,"median":-19.705365,"eighty":-10.310089,"marketCap":2776040603},{"date":"2026-06-12","current":-21.794185,"twenty":-24.818526,"median":-19.734054,"eighty":-10.313341,"marketCap":3077382440},{"date":"2026-06-18","current":-18.776621,"twenty":-24.802267,"median":-19.684963,"eighty":-10.332349,"marketCap":3198353220},{"date":"2026-06-26","current":-20.13271,"twenty":-24.776789,"median":-19.66456,"eighty":-10.358393,"marketCap":3429345397},{"date":"2026-07-02","current":-21.747499,"twenty":-24.722332,"median":-19.762743,"eighty":-10.368595,"marketCap":3704403773},{"date":"2026-07-10","current":-23.007619,"twenty":-24.651853,"median":-19.829477,"eighty":-10.39842,"marketCap":3919048812},{"date":"2026-07-17","current":-19.206397,"twenty":-24.633491,"median":-19.854838,"eighty":-10.468301,"marketCap":3271559971},{"date":"2026-07-24","current":-21.196718,"twenty":-24.602614,"median":-19.924318,"eighty":-10.512193,"marketCap":3610585412},{"date":"2026-07-31","current":-20.641765,"twenty":-24.584569,"median":-19.948142,"eighty":-10.52082,"marketCap":3516056306},{"date":"2026-08-07","current":-21.956128,"twenty":-24.559431,"median":-19.978813,"eighty":-10.545017,"marketCap":3739941031},{"date":"2026-08-14","current":-18.156488,"twenty":-24.476043,"median":-19.948142,"eighty":-10.550775,"marketCap":3900649177},{"date":"2026-08-21","current":-16.769027,"twenty":-24.436431,"median":-19.854838,"eighty":-10.567565,"marketCap":3602573975}],"updateTime":1787427786337},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GPCR\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620247033","title":"This biotech is working on a GLP-1 pill that could be better than the Wegovy version","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247033","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247033?lang=en_us&edition=fundamental","pubTime":"2026-03-18 03:20","pubTimestamp":1773775200,"startTime":"0","endTime":"0","summary":"Structure Therapeutics said its experimental pill helped people lose about 16% of their body weight after about a year of treatment. Structure Therapeutics is one of several companies developing new GLP-1 pills to help people lose weight.This article has been updated to correct the comparable weight loss and discontinuation rate for the Wegovy pill.Shares of Structure Therapeutics rallied 5.4% on Monday after the company said higher doses of its experimental GLP-1 pill led to greater weight loss.The biotech company said patients taking aleniglipron for 11 months in a Phase 2 trial had placebo-adjusted weight loss of 16.3% for the 180 mg dose and 16.0% for the 240 mg dose.Late last year, Structure  shared data for the same drug in the same trial, and cited placebo-adjusted weight loss of 11.3% after nine months at the 120 mg dose. Weeks later, it announced a royalty and licensing deal with Roche  that gave the biotech $100 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4590","GPCR","GLP","BK4144","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140086010","title":"Eli Lilly Shares Decline Over 4% as Structure Therapeutics Reports Positive Data for Experimental Weight-Loss Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1140086010","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140086010?lang=en_us&edition=fundamental","pubTime":"2026-03-17 23:25","pubTimestamp":1773761113,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY.US) shares opened lower and extended losses on Tuesday, falling more than 4% to $948.76 at the time of writing. The decline follows news that Structure Therapeutics (GPCR.US) announced...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109391861.USD","LU2756315664.SGD","LU2471134879.HKD","LU2264538146.SGD","LU1023059063.AUD","LU0097036916.USD","SG9999013999.USD","LU0114720955.EUR","LU0354030438.USD","SG9999017495.SGD","GB00BDT5M118.USD","LU0708995401.HKD","LU0672654240.SGD","LU1551013425.SGD","SGXZ57979304.SGD","LU2089283258.USD","LU2746668974.SGD","LU1093756168.USD","LU0289739699.SGD","LU1232071149.USD","BK4533","LU2324357040.USD","IE00BJJMRX11.SGD","LU1868836757.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0640476718.USD","IE0009355771.USD","LU0385154629.USD","LU2491050071.SGD","LU0964807845.USD","IE0001KFT4U8.USD","LU0203202063.USD","LU2237443622.USD","IE00B4JS1V06.HKD","LU2552382215.SGD","BK4534","LU1983299246.USD","LU0316494557.USD","LU2471134952.CNY","IE00BJT1NW94.SGD","LU0432979614.USD","LU2237443978.SGD","LU1989771016.USD","LU1804176565.USD","LU2111349929.HKD","SG9999015986.USD","LU2112291526.USD","LU0109394709.USD","LU0353189763.USD","LU1093756325.SGD","LU1988902786.USD","LU0882574139.USD","LU1127390331.HKD","LU1623119135.USD","SG9999018865.SGD","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU0889565916.HKD","GPCR","IE0002141913.USD","IE00B1XK9C88.USD","LLY","LU0158827781.USD","LU2357305700.SGD","LU0820561818.USD","LU0006306889.USD","LU1061106388.HKD","LU2461242641.AUD","IE00B2B36J28.USD","LU0094547139.USD","SGXZ81514606.USD","LU2265009873.SGD","LU0058720904.USD","LU0471298777.SGD","LU0417517546.SGD","LU2896262040.SGD","LU2213496289.HKD","LLYX","SGXZ99366536.SGD","LU1323610961.USD","BK4516","LU0820562030.AUD","IE00BK4W5M84.HKD","LU2023250504.SGD","LU2028103732.USD","LU2211815571.USD","LU0823434740.USD","IE00BFSS7M15.SGD","LU2168564495.EUR","ELIL","IE00BJLML261.HKD","LU0158827948.USD","LLYZ","LU1868837300.USD","LU2456880835.USD","LU0456855351.SGD","LU0787776722.HKD","LU1720051017.SGD","IE00B775H168.HKD","LU1035775433.USD","LU2750360997.AUD","SG9999014898.SGD","IE00BN29S564.USD","IE00B1BXHZ80.USD","LU2023250330.USD","LU2236285917.USD","LU0823416689.USD","LU1868837136.USD","LU2756315318.SGD","IE00BKPKM429.USD","IE0005OL40V9.USD","SG9999018857.SGD","LU1145028129.USD","LU2468319806.SGD","LU0256863811.USD","LU2108987350.USD","LU2089284900.SGD","LU0256863902.USD","LU2552382132.HKD","LU0820561909.HKD","LU0320765992.SGD","LU1868836591.USD","IE0004445239.USD","LU1974910355.USD","LU2106854487.HKD","LU0210536198.USD","LU0079474960.USD","LU0786609619.USD","LU1366192091.USD","LU2087625088.SGD","LU2168564222.USD","LU2361044865.SGD","LLII","LU0061475181.USD","LU0689472784.USD","LU0823434583.USD","LU2168564149.EUR","SG9999014880.SGD","LU2361044949.HKD","LU1712237335.SGD","LU2491050154.USD","SG9999001176.SGD","LU2023251221.USD","LU1057294990.SGD","SG9999015945.SGD","LU1551013342.USD","LU1814569148.SGD","LU0238689110.USD","SGXZ51526630.SGD","LU2237443549.SGD","SG9999014914.USD","LU2417539215.USD","LU0882574055.USD","LU1868836914.USD","LU2063271972.USD","LU0354030511.USD","SGXZ31699556.SGD","IE00BJJMRY28.SGD","LU2237443895.HKD","SG9999014906.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","BK4007","IE00BKDWB100.SGD","LU2168564065.EUR","LU1720051108.HKD","LU2746668461.USD","SG9999001176.USD","LU0234572021.USD","LU2491049909.HKD","BK4599","LU0466842654.USD","LU0683600562.USD","LU2271345857.HKD","LU2237443465.HKD","LU0471298694.HKD","LU2462157665.USD","BK4588","LU0225283273.USD","LU1548497426.USD","LU0266013472.USD","LU0198837287.USD","IE00BWXC8680.SGD","LU2471134523.USD","LU1917777945.USD","LU1267930730.SGD","LU2237443382.USD","SG9999015978.USD","LU2360106947.USD","BK4581","LU1629891620.HKD","BK4585","IE0004445015.USD","LU0323591593.USD","LU2168563687.JPY","LU2602419157.SGD","LU1069344957.HKD","IE00B7KXQ091.USD","LU2471134796.USD","LU2750360641.GBP","IE00BK4W5L77.USD","LU0320765059.SGD","ELIS","LU0353189680.USD","LU0106261372.USD","LU1291159041.SGD","LU0096364046.USD","LU1064131342.USD","LU1280957306.USD","LU2552382058.USD","LU2361045086.USD","LU0203201768.USD","LU0943347566.SGD","LU2237438978.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620712429","title":"Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620712429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620712429?lang=en_us&edition=fundamental","pubTime":"2026-03-17 19:30","pubTimestamp":1773747015,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Merit Medical Systems (MMSI – Research Report), Voya...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merit-medical-systems-mmsi-voyager-therapeutics-vygr-and-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merit-medical-systems-mmsi-voyager-therapeutics-vygr-and-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1559883803.SGD","BK4007","LU0128526141.USD","VYGR","BK4599","GPCR","LU0029874061.USD","MMSI","BK4588","BK4585","XBI","BK4198","XLV","HCSG","LABU","LU0566484027.USD","BK4137","BK4139","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620493529","title":"BUZZ-U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2620493529","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620493529?lang=en_us&edition=fundamental","pubTime":"2026-03-17 02:03","pubTimestamp":1773684181,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Customers Bancorp, Forgent Power Solutions, NvidiaWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL6N4040NI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLUE","BHAT","DLTR","BAX","PAVS","AXR","CRCD","RIOT","ULY","WNW","NEO","CDE","INTU","SOC","ULYX","FPS","CF","COGT","MOS","NVDB","HCWB","AU","GPCR","ABOS","HL","CUBI","MRAL","COIG","NSA","PFSI","NVDS.UK","ZEPP","NVDG","NEM","TSQ","TECH","NVDA","DIPS","PSA","ALIT","LYRA","CIEN"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2619021462","title":"Structure Therapeutics Inc. : H.c. Wainwright Cuts Target Price to $100 From $114","url":"https://stock-news.laohu8.com/highlight/detail?id=2619021462","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619021462?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:50","pubTimestamp":1773676234,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nAZN4SLI4E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619246227","title":"BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, Micron, Customers Bancorp","url":"https://stock-news.laohu8.com/highlight/detail?id=2619246227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619246227?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:42","pubTimestamp":1773675731,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Dollar Tree, Micron, Customers BancorpWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL6N40412P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MU","ICRC","COIG","RIOX","UPST","GPCR","ULYX","LDOS","HCWB","BHAT","CDE","GLUE","AXR","AU","ZEPP","NEO","ALIT","DLTR","NBIG","SOC","MOS","PAVS","COGT","ABOS","CRCA","CIEN","ULY","TSQ","INTU","NSA","HL","CF","NWMX","PSA","RTYY","WNW","BAX","PFSI","RIOT","UAMY","CAST","NBIZ","CUBI","NEM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2619462572","title":"Structure’s GLP-1 pill could put company on M&A radar, Barron’s says","url":"https://stock-news.laohu8.com/highlight/detail?id=2619462572","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619462572?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:10","pubTimestamp":1773673826,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) said its GLP-1 pill helped patients lose over 16% of their weight, on average, in a 10-month drug trial, Bill Alpert ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structures-glp-1-pill-could-put-company-on-ma-radar-barrons-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structures-glp-1-pill-could-put-company-on-ma-radar-barrons-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","GLP","BK4144","BK4590","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619545464","title":"Weight Loss Pill from Structure Therapeutics Trimmed the Most Pounds Yet. Is the Biotech a Takeover Candidate? -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2619545464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619545464?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:46","pubTimestamp":1773672360,"startTime":"0","endTime":"0","summary":"The biotech firm Structure Therapeutics said its GLP-1 pill helped patients lose over 16% of their weight, on average, in a 10-month drug trial. Weight loss continued the longer patients took the pill, with no plateau in sight, the company said.That's more weight loss than was achieved in studies of the Wegovy pill that Novo Nordisk began marketing in January, or a pill that Eli Lilly is expected to launch soon. In premarket trading Monday, Structure stock was up 10%, to $59.Monday's results were for two high doses of Structure's pill, aleniglipron. The company previously reported weight loss of 15% on a lower dose. Monday's announcement said that patients who'd remained on that lower dose lost up to 16% of their weight in 53 weeks. Side effects and dropouts from the studies were in line with those of most GLP-1 drugs, Structure said.These Phase 2 results will help Structure decide the dose to use when it begins a Phase 3 trial in the second half of this year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4007","LENZ","GPCR","BK4581","BK4588","BK4599","BK4585","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619466628","title":"Structure Therapeutics Shares up 6% After Disclosing Mid-Stage Trial Results of Experimental Obesity Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2619466628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619466628?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:31","pubTimestamp":1773667868,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN40407Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619463573","title":"Structure Stock Rises on Positive Data From Oral GLP-1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2619463573","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619463573?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:41","pubTimestamp":1773664860,"startTime":"0","endTime":"0","summary":"The stock of Structure Therapeutics rose after the company reported positive topline data from a phase two study of its aleniglipron oral GLP-1 drug.The stock rose 8% to $58.07 in premarket trading and has more than doubled over the past 12 months.The company said the drug showed the highest efficacy among oral GLP-1 drugs and comparable efficacy to injectable GLP-1s.The drug showed placebo-adjusted mean weight loss of 16.3% at 180 milligrams and 16.0% at 240 milligrams at 44 weeks with no evidence of weight loss plateau.\"The consistent weight loss observed across multiple studies to date reaffirms aleniglipron's potential to be a best-in-class oral GLP-1, with injectable-like efficacy that could become a backbone oral small molecule therapy for obesity,\" said Chief Executive Raymond Stevens.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4007","GPCR","GLP","BK4144","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619029450","title":"This biotech is working on an GLP-1 drug that could be better than the Wegovy pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2619029450","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619029450?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:27","pubTimestamp":1773664020,"startTime":"0","endTime":"0","summary":"Structure Therapeutics said its experimental pill helped people lose about 16% of their body weight after about a year of treatment. Structure Therapeutics is one of several companies developing new GLP-1 pills to help people lose weight.Shares of Structure Therapeutics rallied 10% in premarket trade on Monday after the company said higher doses of its experimental GLP-1 pill led to greater weight loss.The biotech company said patients taking aleniglipron for 11 months in a Phase 2 trial had placebo-adjusted weight loss of 16.3% for the 180 mg dose and 16.0% for the 240 mg dose.Late last year, Structure  shared data for the same drug in the same trial, and cited weight loss of 11.3% after nine months at the 120 mg dose. Weeks later, it announced a royalty and licensing deal with Roche  that gave the biotech $100 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","BK4144","BK4590","BK4599","GPCR","RHHBY","BK4007","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619450651","title":"BRIEF-Structure Therapeutics Reports Positive Topline Data From Phase 2 Access Ii Trial With Once-Daily Oral Small Molecule Glp-1 Receptor Agonist, Aleniglipron","url":"https://stock-news.laohu8.com/highlight/detail?id=2619450651","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619450651?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:40","pubTimestamp":1773661224,"startTime":"0","endTime":"0","summary":"BRIEF-Structure Therapeutics Reports Positive Topline Data From Phase 2 Access Ii Trial With Once-Daily Oral Small Molecule Glp-1 Receptor Agonist, AleniglipronMarch 16 (Reuters) - Structure Therapeut","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUAC932FB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619457137","title":"Structure Therapeutics Shares Reverse Course; Last up 13.5% Premarket After Disclosing Mid-Stage Trial Results of Experimental Obesity Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2619457137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619457137?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:23","pubTimestamp":1773660194,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN4040H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619345202","title":"Structure Therapeutics Shares Down 1.6% Premarket After Disclosing Mid-Stage Trial Results of Experimental Obesity Pill","url":"https://stock-news.laohu8.com/highlight/detail?id=2619345202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619345202?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:10","pubTimestamp":1773659442,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nFWN4040H3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619452438","title":"Structure's obesity pill shows up to 16.3% weight loss in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2619452438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619452438?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:04","pubTimestamp":1773659041,"startTime":"0","endTime":"0","summary":"Structure's obesity pill shows up to 16.3% weight loss in studyMarch 16  - Structure Therapeutics GPCR.O said its oral obesity drug aleniglipron delivered up to 16.3% weight loss, when compared with a placebo after 44 weeks of treatment in a midstage study.  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL4N4040WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619145248","title":"Structure Therapeutics reports 16.3% placebo-adjusted weight loss at 44 weeks in Phase 2 ACCESS II trial of oral GLP-1 agonist aleniglipron","url":"https://stock-news.laohu8.com/highlight/detail?id=2619145248","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619145248?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:03","pubTimestamp":1773659003,"startTime":"0","endTime":"0","summary":"Structure Therapeutics reports 16.3% placebo-adjusted weight loss at 44 weeks in Phase 2 ACCESS II trial of oral GLP-1 agonist aleniglipron. Structure Therapeutics reported topline 44-week results from the Phase 2 ACCESS II trial of once-daily oral GLP-1 receptor agonist aleniglipron in 85 adults with obesity or overweight plus at least one weight-related comorbidity. At 44 weeks, placebo-adjusted mean weight loss was 16.3% at 180 mg and 16% at 240 mg. In an interim analysis of the ACCESS open-label extension at 56 weeks, weight loss from baseline reached 16.2% with the 120 mg dose. In ACCESS II, mean percent change in body weight at 44 weeks was -15.3% at 180 mg and +1.1% for placebo. Structure Therapeutics said a Type B End-of-Phase 2 meeting with the FDA is scheduled for Q2 2026 and Phase 3 initiation is planned for 2H 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL2MFkvc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","IE00B3QW5Z07.USD","BK4112","SG9999014039.USD","BK4007","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","BK4588","IE00BN0W2W23.USD","SG9999014013.SGD","SG9999014005.SGD","NDAQ","IE00BN0W2V16.EUR","BK4599","LU2210149790.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014021.USD","LU0314104364.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619526564","title":"Structure Therapeutics Inc - Interim Data Shows 2.0%-3.4% Ae-Related Discontinuations With 2.5 Mg Starting Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2619526564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619526564?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:00","pubTimestamp":1773658803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUAC932FB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619452689","title":"Structure Therapeutics Inc - Access Ole Study Shows Continued Weight Loss up to 16.2% With 120 Mg at 56 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2619452689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619452689?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:00","pubTimestamp":1773658803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUAC932FB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GPCR","BK4599","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619452660","title":"Structure Therapeutics Inc - End-of-Phase 2 FDA Meeting Scheduled for Q2 2026; Phase 3 Initiation on Track for 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2619452660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619452660?lang=en_us&edition=fundamental","pubTime":"2026-03-16 19:00","pubTimestamp":1773658803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUAC932FB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GPCR","BK4007","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618604323","title":"Septerna: Novo-Backed GPCR Platform and Best-in-Class Potential for Oral MRGPRX2 Inhibitor SEP-631 Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618604323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618604323?lang=en_us&edition=fundamental","pubTime":"2026-03-10 09:45","pubTimestamp":1773107121,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Yaron Werber has maintained their bullish stance on SEPN stock, giving a Buy rating on March 3. Yaron Werber has given his Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/septerna-novo-backed-gpcr-platform-and-best-in-class-potential-for-oral-mrgprx2-inhibitor-sep-631-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/septerna-novo-backed-gpcr-platform-and-best-in-class-potential-for-oral-mrgprx2-inhibitor-sep-631-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN","GPCR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":95,"code":"91000000","status":"200"}]}}